Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, …
“World stock indexes have struggled to continue the rally that began in 2009. Investors have begun to question the validity of the rally. However, there are small pockets of strength McCall continues to say, “With approximately 160 biotech …
OMP is looking to trade as "OMPI" on the Nasdaq. Listed as a day-to-day possibility is biotech company Xenogen, which has been on deck since mid-January. "If they don't make it this week they will probably be pulled off the calendar …
The less things change, the more time everyone has to speculate about what might happen if things do change. As expected, the Federal Reserve’s FOMC today announced that it is leaving the overnight lending rate unchanged at …
EDITOR’S COMMENTS..... 2 CONTRIBUTORS..... 4 ...
There is none who has given such a treasure of wisdom like him." Here is the heart of the work: Verse 244 — "Mannuyir …
This evolution is proportional to the recent spike in activity. It is mainly due to the increase in purchases as a result of rising sales, but also to the payment of stock exchange listing fees, fees related to the filing and issuance of patents …
-Conference Call To Be Held at 4:30 PM EDT Today- Al Hummel, the Company’s President and CEO, stated, “We are pleased to have brought the Zein Obagi litigation to closure. Although public disclosure of certain of the non-economic …